Supernus Pharmaceuticals (SUPN) Current Deferred Tax Assets (2015)

Supernus Pharmaceuticals (SUPN) reported Current Deferred Tax Assets of -$200000.0 for Q4 2015.

Supernus Pharmaceuticals (SUPN) Current Deferred Tax Assets (2015) Analysis & Trends

Supernus Pharmaceuticals (SUPN) has 1 years of Current Deferred Tax Assets data on file, last reported at -$200000.0 in Q4 2015.

Current Deferred Tax Assets for Q4 2015 came in at -$200000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was -$200000.0 (changed N/A YoY), and the FY2015 annual result was -$200000.0, changed N/A from the prior year.
Current Deferred Tax Assets steadied at -$200000.0 in Q4 2015 per SUPN's latest filing.
Over five years, Current Deferred Tax Assets peaked at -$200000.0 in Q4 2015 and troughed at -$200000.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Supernus Pharmaceuticals	2.63 Bn	2.24 Bn	-

Download Data

Date	Value
Dec 31, 2015	-200,000.00
Dec 31, 2015	-200,000.00